Unresectable, Non-metastatic Hepatocellular Carcinoma
2 clinical trials · Condition
◉ Watch Unresectable, Non-metastatic Hepatocellular Carcinoma
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of AK104 Plus Lenvatinib and TACE in HCC (NCT05319431) | Akeso | 2022-06-28 |
| Treatment of Cirrhosis-related Hepatocellular Carcinoma With the Intrahepatic Arterial Injection of an Emulsion of Lipiodol and Idarubicin (Zavedos®): Phase I Study (NCT02028949) | Centre Hospitalier Universitaire Dijon | 2012-11-22 |
Track Unresectable, Non-metastatic Hepatocellular Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.